Pulmonary sarcoidosis
MONDO:0001708Sarcoidosis affecting the lung parenchyma. It is characterized by the presence of non-necrotizing granulomas in the lung tissues. It is manifested with dyspnea, cough, fever, night sweats, fatigue, and weight loss.
Also known as: lung sarcoidosis, sarcoidosis of lung
89 clinical trials for this condition and its sub-types, 20 tagged with Pulmonary sarcoidosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New drug aims to cut steroid use in lung sarcoidosis
Disease control CompletedThis Phase 3 trial tested a drug called efzofitimod in 268 adults with pulmonary sarcoidosis, a condition that causes lung inflammation. Participants received either the drug or a placebo every 4 weeks for 48 weeks. The main goal was to see if the drug could help people safely re…
Phase 3 • Sponsor: aTyr Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New biopsy technique may boost sarcoidosis diagnosis rates
Diagnosis CompletedThis study tested whether adding a tiny forceps biopsy to the standard needle biopsy during a lung ultrasound procedure helps doctors diagnose sarcoidosis more often. Fifty-five adults with enlarged lymph nodes in the chest took part. The goal was to see if the combined approach …
Sponsor: George Washington University • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
Lung rehab boosts daily activity in advanced sarcoidosis patients
Symptom relief CompletedThis study looked at whether a pulmonary rehabilitation program helps people with Stage IV pulmonary sarcoidosis (advanced lung scarring) become more active in their daily lives. 38 adults took part and were followed for one year. The program aimed to improve exercise ability, re…
Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Does a common sarcoidosis treatment raise lymphoma risk? new study investigates
Knowledge-focused CompletedThis completed study from Alexandria University looked at 40 adults with lung sarcoidosis who were receiving or about to start immunosuppressive therapy. Researchers tracked them for 12 months to see if any developed lymphoma, confirmed by lymph node biopsy. The goal was to under…
Sponsor: Alexandria University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC